Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2025-12-25 @ 4:14 AM
NCT ID:
NCT00498420
Eligibility Criteria:
Inclusion Criteria:
1. The patient (or patient's legal guardian) must provide written informed consent prior to performing any survey-related procedures.
2. The patient must have a documented diagnosis of Alpha Mannosidosis, confirmed at screening by measurable clinical signs and symptoms of Alpha Mannosidosis
3. Documented deficiency of serum or leukocyte acid alpha-mannosidase enzyme activity level
Exclusion Criteria:
1. History of bone marrow transplantation.
2. Use of an investigational drug within 30 days prior to study enrollment.
3. Known medical condition, serious intercurrent illness, or other extenuating circumstance that may significantly decrease study compliance.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00498420
Study Brief:
Protocol Section:
NCT00498420